X0306 4 2019-09-20 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001695580 Krogulski Kenneth 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203 1 0 0 0 Common Stock 2019-09-20 4 P 0 65 5.33 A 161422 D Common Stock 2019-09-23 4 P 0 65 5.35 A 164287 D Common Stock 2019-09-24 4 P 0 65 5.39 A 164352 D Common Stock 2019-09-25 4 P 0 65 5.38 A 164417 D Common Stock 2019-09-26 4 P 0 65 5.76 A 164482 D Common Stock 2019-09-27 4 P 0 65 5.76 A 164547 D Common Stock 2019-09-30 4 P 0 65 5.89 A 164612 D Common Stock 2019-10-01 4 P 0 65 5.89 A 164677 D Common Stock 2019-10-02 4 P 0 65 5.77 A 164742 D Common Stock 2019-10-04 4 P 0 65 5.76 A 164807 D Common Stock 2019-10-07 4 P 0 65 5.74 A 164872 D Common Stock 2019-10-08 4 P 0 65 5.81 A 164937 D Common Stock 2019-10-09 4 P 0 65 5.78 A 165002 D Common Stock 2019-10-10 4 P 0 65 5.86 A 165067 D Common Stock 2019-10-11 4 P 0 65 5.71 A 165132 D Common Stock 2019-10-14 4 P 0 65 5.67 A 165197 D Common Stock 2019-10-15 4 P 0 65 5.63 A 165262 D Common Stock 2019-10-16 4 P 0 65 5.56 A 165327 D Common Stock 2019-10-17 4 P 0 65 5.52 A 165392 D Common Stock 2019-10-18 4 P 0 65 5.45 A 165457 D Common Stock 2019-10-19 4 P 0 38 5.51 A 165495 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. Kenneth J. Krogulski by /s/ Michael Bonner as attorney-in-fact 2019-10-25